!
!
Sign in / Join ICS
Home
An Evaluation of SER120 Nasal Spray in Patients with Nocturia - Results of the Pooled Analyses of 2 Phase III Randomized, Double-Blind, Placebo Controlled Studies
Wein A
1
, Dmochowski R
2
, Cheng L
3
, Cheng M
3
, Abrams S
4
, Herschkowitz S
3
, Fein S
3
Research Type
Clinical
Abstract Category
Nocturia
Abstract 234
Rapid Communications in Urology
Scientific Podium Express Session 13
Wednesday 14th September 2016
16:57 - 17:00
Hall D5
Clinical Trial
Nocturia
Quality of Life (QoL)
Voiding Dysfunction
1.
University of Pennsylvania,
2.
Vanderbilt University,
3.
Serenity Pharmaceuticals,
4.
Allergan plc
Presenter
A
Alan Wein
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
17/04/2024 16:00:42